Scholarly Index
Myron S. Cohen
University of North Carolina at Chapel Hill; 53,976 total citations; 712 total publications; best world rank #13
University of North Carolina at Chapel Hill
53,976Total citations
712Total publications
114H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| HIV/AIDS Research and Interventions | Lifetime | 14 | US 11 | 99.91 |
| HIV Research and Treatment | Lifetime | 43 | US 38 | 99.81 |
| Reproductive tract infections research | Lifetime | 24 | US 14 | 99.59 |
| Syphilis Diagnosis and Treatment | Lifetime | 13 | US 9 | 99.56 |
| HIV, Drug Use, Sexual Risk | Lifetime | 38 | US 24 | 99.64 |
| Sex work and related issues | Lifetime | 30 | US 22 | 99.41 |
| HIV/AIDS drug development and treatment | Lifetime | 102 | US 60 | 99.47 |
| Adolescent Sexual and Reproductive Health | Lifetime | 84 | US 54 | 99.38 |
| Bacterial Infections and Vaccines | Lifetime | 185 | US 76 | 98.35 |
| Neutrophil, Myeloperoxidase and Oxidative Mechanisms | Lifetime | 182 | US 93 | 98.20 |
| COVID-19 Clinical Research Studies | Lifetime | 743 | US 174 | 97.40 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 793 | US 268 | 97.54 |
| Paraquat toxicity studies and treatments | Lifetime | 811 | US 142 | 50.96 |
| COVID-19 Clinical Research Studies | 2021-2025 | 640 | US 149 | 97.25 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 981 | US 303 | 96.44 |
| HIV Research and Treatment | 2021-2025 | 473 | US 224 | 91.74 |
| HIV/AIDS drug development and treatment | 2021-2025 | 494 | US 160 | 88.20 |